Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
Share your views on the New York mayoral election results
5/11/2025
Other People’s Fun by Harriet Lane review – darkly comic tale of envy and revenge in the Insta age
5/11/2025
Camouflage clothing may be having a moment – but in our violent world, is that wise ? | Ellie Violet Bramley
5/11/2025
Odyssey review – estate agents, cocaine and mental collapse in a jagged London thriller
5/11/2025
‘All those silly things – do them’ : Guruzeta’s journey from gurney to goals with Athletic
5/11/2025
Enzo Maresca must decide to stick or twist on Chelsea’s epic Qarabag trek
5/11/2025